Tenax Therapeutics, Inc. (TENX) stock
TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.48−0.14 (-8.64%)
Close on Nov 16, 2026Market cap $55.39MP/E –Yield –
Tenax Therapeutics cash
Cash and short-term investments held at the end of each period.
Tenax Therapeutics's cash was $118.00M at Jun 30, 2026. For fiscal 2025 it was $97.57M, up 2.9% from the year before. Over ten years it grew 5.3% a year on average. The highest annual figure on record is $97.57M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $97.57M | +2.9% |
| FY2024 | Dec 31, 2024 | $94.85M | +868.7% |
| FY2023 | Dec 31, 2023 | $9.79M | +361.0% |
| FY2022 | Dec 31, 2022 | $2.12M | -62.0% |
| FY2021 | Dec 31, 2021 | $5.58M | -16.8% |
| FY2020 | Dec 31, 2020 | $6.71M | +24.3% |
| FY2019 | Dec 31, 2019 | $5.40M | -58.0% |
| FY2018 | Dec 31, 2018 | $12.86M | +66.5% |
| FY2017 | Dec 31, 2017 | $7.73M | -54.9% |
| FY2015 | Apr 30, 2015 | $17.13M | -70.6% |
| FY2014 | Apr 30, 2014 | $58.32M | +7343.3% |
| FY2013 | Apr 30, 2013 | $783.53K | -58.3% |
| FY2012 | Apr 30, 2012 | $1.88M | +97.5% |
| FY2011 | Apr 30, 2011 | $951.94K | +50.5% |
| FY2010 | Apr 30, 2010 | $632.71K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $118.00M | +11.9% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $118.80M | +6.6% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $97.57M | +2.9% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $99.40M | +1.1% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $105.46M | +1023.8% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $111.45M | +788.1% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $94.85M | +868.7% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $98.31M | +782.4% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $9.38M | -29.9% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $12.55M | -12.9% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $9.79M | +361.0% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $11.14M | +192.7% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $13.39M | +85.3% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $14.41M | +402.5% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $2.12M | -62.0% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $3.81M | -54.4% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $7.23M | +231.3% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $2.87M | -28.8% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $5.58M | -16.8% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $8.35M | -4.1% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $2.18M | -52.1% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $4.03M | -17.0% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $6.71M | +24.3% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $8.71M | +22.2% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $4.55M | -48.9% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $4.86M | -55.1% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $5.40M | -58.0% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $7.13M | +46.8% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $8.91M | +39.1% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $10.82M | +63.6% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $12.86M | +66.5% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $4.86M | -43.1% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $6.41M | -27.2% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $6.62M | -47.2% |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $7.73M | -54.9% |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | $8.53M | -50.0% |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | $8.80M | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | $12.52M | – |
| Q4 FY2015CQ1 2015 | Apr 30, 2015 | $17.13M | – |
| Q3 FY2015CQ4 2014 | Jan 31, 2015 | $17.07M | – |
See a number that looks wrong?